Iceland· IS-EU/1/20/1502/001-002

Roclanda

A latanoprost and netarsudil product containing netarsudilum inn mesýlat,netarsudilum inn,latanoprostum inn, registered in Iceland by Santen Oy*. The same ATC class is registered in 14 of our 19 countries.

ATC S01EE51

Checked against Icelandic Medicines Agency (Iceland) on

Informational only — not a medical device.

SOURCE REGISTER · ISIcelandic Medicines Agency (Iceland)normalisedRoclandaATCS01EE51REGISTER NO.IS-EU/1/20/1502/001-0…PACKS LISTED2CHECKEDSeptember 29, 2026

Where it is registered

Latanoprost and netarsudil is registered in 14 of 19 countries.

Countries holding a registration under ATC S01EE51 (latanoprost and netarsudil), each read from that country’s own register.

  • This record: Iceland, from Icelandic Medicines Agency (Iceland)
  • 10 of them publish a price we can compare per daily dose

Latanoprost and netarsudil · ATC S01EE51

14 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Icelandic Medicines Agency (Iceland)
Active substance
Netarsudilum INN mesýlat,Netarsudilum INN,Latanoprostum INN
Manufacturer
Santen Oy*
Country
Iceland (IS)
ATC code
S01EE51
ATC class
Latanoprost and netarsudil
Defined daily dose
0.1 ml, AT
Reimbursed
Not published by this register
Source register
Icelandic Medicines Agency (Iceland)
Last checked
September 29, 2026

Packs & prices · 2

2 priced
  • ean
    057731
    2,5 ml x1 glas
    ISK 4464
  • ean
    535505
    2,5 ml x3 glös
    ISK 10914

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Latanoprost and netarsudil in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All latanoprost and netarsudil products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • Liechtenstein · Roclanda
  • Norway · Roclanda

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/91a15de7-a49f-4418-a781-f16371969d78
GET /v1/drugs/91a15de7-a49f-4418-a781-f16371969d78?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Augndropar, lausn",
  "source": "lyfjastofnun",
  "atc_raw": "S01EE51",
  "marketed": true,
  "strength": "50 míkrógrömm/ml + 200 míkróg/ml",
  "ma_number": "EU/1/20/1502/001-002",
  "substance": "Netarsudilum INN mesýlat,Netarsudilum INN,Latanoprostum INN",
  "other_info": "Ávísun lyfsins er bundin við sérfræðinga í augnlækningum.",
  "legal_status": "(R Z) Sérfræðingsmerkt (og lyfseðilsskylt)",
  "ma_issued_serial": "44203"
}

See everything about latanoprost and netarsudil.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.